Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9-10
|
pubmed:dateCreated |
1976-9-1
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0017-0275
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
330-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1228050-Adult,
pubmed-meshheading:1228050-Ascitic Fluid,
pubmed-meshheading:1228050-Epinephrine,
pubmed-meshheading:1228050-Humans,
pubmed-meshheading:1228050-Kidney Diseases,
pubmed-meshheading:1228050-Liver Diseases,
pubmed-meshheading:1228050-Male,
pubmed-meshheading:1228050-Middle Aged,
pubmed-meshheading:1228050-Plasma Substitutes,
pubmed-meshheading:1228050-Prednisolone
|
pubmed:articleTitle |
[Current therapeutic prospects in the hepatorenal syndrome].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|